These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36846137)

  • 61. TPPU, a sEH Inhibitor, Attenuates Corticosterone-Induced PC12 Cell Injury by Modulation of BDNF-TrkB Pathway.
    Wu Q; Song J; Meng D; Chang Q
    J Mol Neurosci; 2019 Mar; 67(3):364-372. PubMed ID: 30644034
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke.
    Huang H; Al-Shabrawey M; Wang MH
    Prostaglandins Other Lipid Mediat; 2016 Jan; 122():45-53. PubMed ID: 26747234
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
    Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
    PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
    [TBL] [Abstract][Full Text] [Related]  

  • 64. TPPU Downregulates Oxidative Stress Damage and Induces BDNF Expression in PC-12 Cells.
    Wu Q; Lin M; Wu P; Zhao C; Yang S; Yu H; Xian W; Song J
    Comput Math Methods Med; 2022; 2022():7083022. PubMed ID: 35872930
    [TBL] [Abstract][Full Text] [Related]  

  • 65. TPPU Pre-Treatment Rescues Dendritic Spine Loss and Alleviates Depressive Behaviours during the Latent Period in the Lithium Chloride-Pilocarpine-Induced Status Epilepticus Rat Model.
    Peng W; Shen Y; Wang Q; Ding J; Wang X
    Brain Sci; 2021 Nov; 11(11):. PubMed ID: 34827464
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibition of Soluble Epoxide Hydrolase in Macrophages Ameliorates the Formation of Foam Cells　- Role of Heme Oxygenase-1.
    Peng H; Tang J; Zhao S; Shen L; Xu D
    Circ J; 2019 Nov; 83(12):2555-2566. PubMed ID: 31666457
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.
    Chaudhary KR; Abukhashim M; Hwang SH; Hammock BD; Seubert JM
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):67-73. PubMed ID: 19834332
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Contribution of DHA diols (19,20-DHDP) produced by cytochrome P450s and soluble epoxide hydrolase to the beneficial effects of DHA supplementation in the brains of rotenone-induced rat models of Parkinson's disease.
    Oguro A; Ishihara Y; Siswanto FM; Yamazaki T; Ishida A; Imaishi H; Imaoka S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Feb; 1866(2):158858. PubMed ID: 33279658
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of soluble epoxide hydrolase offers protection against fructose-induced diabetes and related metabolic complications in rats.
    Shah SA; Mehmood MH; Khan M; Bukhari IA; Alorainey BI; Vohra F
    J Physiol Pharmacol; 2020 Oct; 71(5):. PubMed ID: 33475089
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis.
    Gurung AB; Mayengbam B; Bhattacharjee A
    Comput Biol Chem; 2018 Jun; 74():1-11. PubMed ID: 29522918
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphine.
    Wan X; Fujita Y; Chang L; Wei Y; Ma L; Wuyun G; Pu Y; Hammock BD; Hashimoto K
    Neuropsychopharmacol Rep; 2020 Dec; 40(4):412-416. PubMed ID: 32896112
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Soluble epoxide hydrolase inhibitors and heart failure.
    Qiu H; Li N; Liu JY; Harris TR; Hammock BD; Chiamvimonvat N
    Cardiovasc Ther; 2011 Apr; 29(2):99-111. PubMed ID: 20433684
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.
    Deng Y; Theken KN; Lee CR
    J Mol Cell Cardiol; 2010 Feb; 48(2):331-41. PubMed ID: 19891972
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive.
    Sasso O; Wagner K; Morisseau C; Inceoglu B; Hammock BD; Piomelli D
    Pharmacol Res; 2015 Jul; 97():7-15. PubMed ID: 25882247
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal Ulcers.
    Goswami SK; Wan D; Yang J; Trindade da Silva CA; Morisseau C; Kodani SD; Yang GY; Inceoglu B; Hammock BD
    J Pharmacol Exp Ther; 2016 Jun; 357(3):529-36. PubMed ID: 26989141
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Soluble epoxide hydrolase inhibition avoid formalin-induced inflammatory hyperalgesia in the temporomandibular joint.
    Abdalla HB; Napimoga MH; Teixeira JM; Trindade-da-Silva CA; Pieroni VL; Dos Santos Araújo FSM; Hammock BD; Clemente-Napimoga JT
    Inflammopharmacology; 2022 Jun; 30(3):981-990. PubMed ID: 35303234
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Soluble epoxide hydrolase inhibition alleviated cognitive impairments via NRG1/ErbB4 signaling after chronic cerebral hypoperfusion induced by bilateral carotid artery stenosis in mice.
    Hao J; Chen Y; Yao E; Liu X
    Brain Res; 2018 Nov; 1699():89-99. PubMed ID: 30343686
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibition of soluble epoxide hydrolase confers cardioprotection and prevents cardiac cytochrome P450 induction by benzo(a)pyrene.
    Aboutabl ME; Zordoky BN; Hammock BD; El-Kadi AO
    J Cardiovasc Pharmacol; 2011 Mar; 57(3):273-81. PubMed ID: 21383588
    [TBL] [Abstract][Full Text] [Related]  

  • 79. sEH Inhibitor Tppu Ameliorates Cecal Ligation and Puncture-Induced Sepsis by Regulating Macrophage Functions.
    Chen Z; Tang Y; Yu J; Dong R; Yang Y; Fu M; Luo J; Hu S; Wang DW; Tu L; Xu X
    Shock; 2020 Jun; 53(6):761-771. PubMed ID: 31318834
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro and in vivo metabolism of N-adamantyl substituted urea-based soluble epoxide hydrolase inhibitors.
    Liu JY; Tsai HJ; Morisseau C; Lango J; Hwang SH; Watanabe T; Kim IH; Hammock BD
    Biochem Pharmacol; 2015 Dec; 98(4):718-31. PubMed ID: 26494425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.